-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Agios Pharmaceuticals, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2019 to Q3 2024.
- Agios Pharmaceuticals, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $112M, a 3.21% increase year-over-year.
- Agios Pharmaceuticals, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $440M, a 7.7% increase year-over-year.
- Agios Pharmaceuticals, Inc. annual Costs and Expenses for 2023 was $418M, a 3.73% increase from 2022.
- Agios Pharmaceuticals, Inc. annual Costs and Expenses for 2022 was $403M, a 6.57% increase from 2021.
- Agios Pharmaceuticals, Inc. annual Costs and Expenses for 2021 was $378M, a 12.7% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)